Letter to the Editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis
We read with great interest the post-hoc analysis by Guttman-Yassky et al. reporting that 21.3% of patients with moderate-to-severe atopic dermatitis (AD) remained free of protocol-defined flare fo...
Authors
- Yusra Hidayat (ORCID: https://orcid.org/0009-0003-8329-6969)
Institutions
- Jinnah Sindh Medical University (PK)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1080/09546634.2026.2690324
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00